Assessment of a prepulse inhibition deficit in a mutant mouse lacking mGlu5 receptors

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Molecular Psychiatry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1038/sj.mp.4001404PMID 14699440
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabotropic Glutamate Subtype 5 Receptors Modulate Locomotor Activity and Sensorimotor Gating in Rodents

  2003cited by this paper
• [3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine Binding to Metabotropic Glutamate Receptor Subtype 5 in Rodent Brain: In Vitro and in Vivo Characterization

  2002cited by this paper
• The mGluR5 antagonist MPEP, but not the mGluR2/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity.

  2002cited by this paper
• Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

  2001cited by this paper
• Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges

  2001cited by this paper
• Comparison of apomorphine, amphetamine and dizocilpine disruptions of prepulse inhibition in inbred and outbred mice strains.

  2001cited by this paper
• Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice

  2001cited by this paper
• Phencyclidine (PCP)-induced deficits of prepulse inhibition in monkeys

  2001cited by this paper
• Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

  2001cited by this paper
• LY354740 affects startle responding but not sensorimotor gating or discriminative effects of phencyclidine.

  2000cited by this paper
• Lack of effect of LY314582 (a group 2 metabotropic glutamate receptor agonist) on phencyclidine-induced locomotor activity in metabotropic glutamate receptor 2 knockout mice.

  2000cited by this paper
• Current Protocols In Neuroscience

  1999cited by this paper
• The up-regulation of metabotropic glutamate receptor 5 (mGluR5) in Down’s syndrome brains

  1999cited by this paper
• Intracerebral administration of metabotropic glutamate receptor agonists disrupts prepulse inhibition of acoustic startle in Sprague-Dawley rats

  1999cited by this paper
• Group I metabotropic glutamate receptors: implications for brain diseases.

  1999cited by this paper
• Measurement of Startle Response, Prepulse Inhibition, and Habituation

  1998cited by this paper
• Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia.

  1998cited by this paper
• Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties.

  1997cited by this paper
• Physical mapping of a glutamate receptor gene in relation to a balanced translocation associated with schizophrenia in a large Scottish family

  1997cited by this paper
• Mice Lacking Metabotropic Glutamate Receptor 5 Show Impaired Learning and Reduced CA1 Long-Term Potentiation (LTP) But Normal CA3 LTP

  1997cited by this paper
• Inbred strain differences in prepulse inhibition of the mouse startle response

  1997cited by this paper
• Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies

  1997cited by this paper
• Psychopharmacology of prepulse inhibition in mice.

  1996cited by this paper
• The effect of ketamine on pre-pulse inhibition and attention

  1995cited by this paper
• Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients.

  1994cited by this paper
• The Metabotropic Glutamate Receptors

  1994cited by this paper
• Startle gating deficits occur across prepulse intensities in schizophrenic patients.

  1992cited by this paper
• Molecular characterization of a novel metabotropic glutamate receptor mGluR5 coupled to inositol phosphate/Ca2+ signal transduction.

  1992cited by this paper
• Gating and habituation of the startle reflex in schizophrenic patients.

  1992cited by this paper
• Sensorimotor gating and schizophrenia. Human and animal model studies.

  1990cited by this paper
• Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat.

  1989cited by this paper
• Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat.

  1989cited by this paper
• Changes in frequency representation in the auditory system of mice with age-related hearing impairment.

  1984cited by this paper
• Reflex modification in the domain of startle: II. The anomalous history of a robust and ubiquitous phenomenon.

  1983cited by this paper
• Reflex modification in the domain of startle: I. Some empirical findings and their implications for how the nervous system processes sensory input.

  1980cited by this paper
• Phencyclidine-induced psychosis.

  1978cited by this paper
• Prestimulus effects on human startle reflex in normals and schizophrenics.

  1978cited by this paper
• Lead-stimulation effects of human cardiac orienting and blink reflexes.

  1975cited by this paper

• The murine ATP-binding cassette transporter C5 (Abcc5/MRP5/cMOAT) plays a role in memory consolidation, circadian rhythm regulation and glutamatergic signalling

  2025cites this paper
• Sex-dependent Schizophrenia and Drug Reward Behavioral Phenotypes in Metabotropic Glutamate 5 Receptor Heterozygous and Homozygous Mice.

  2025cites this paper
• Metabotropic glutamate receptors in GtoPdb v.2025.3

  2025cites this paper
• Lipids shape brain function through ion channel and receptor modulations: physiological mechanisms and clinical perspectives.

  2024cites this paper
• Pharmacology, Signaling and Therapeutic Potential of Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators.

  2024cites this paper
• In and out: Benchmarking in vitro, in vivo, ex vivo, and xenografting approaches for an integrative brain disease modeling pipeline

  2024cites this paper
• Multiple serum anti-glutamate receptor antibody levels in clozapine-treated/naïve patients with treatment-resistant schizophrenia

  2024cites this paper
• Preclinical and translational models for delirium: Recommendations for future research from the NIDUS delirium network

  2023cites this paper
• Metabotropic glutamate receptors in GtoPdb v.2023.1

  2023cites this paper
• Potential of olfactory neuroepithelial cells as a model to study schizophrenia: A focus on GPCRs (Review)

  2023cites this paper
• Alterations in the volume of thalamic nuclei in patients with schizophrenia and persistent auditory hallucinations

  2022cites this paper
• Towards the convergent therapeutic potential of G protein‐coupled receptors in autism spectrum disorders

  2022cites this paper
• NRG1 knockdown rescues PV interneuron GABAergic maturation deficits and schizophrenia behaviors in fetal growth restriction mice

  2022cites this paper
• Loss of schizophrenia-related miR-501-3p in mice impairs sociability and memory by enhancing mGluR5-mediated glutamatergic transmission

  2022cites this paper
• Metabotropic Glutamate Receptors As Emerging Targets for the Treatment of Schizophrenia

  2022cites this paper
• Therapeutic Potential of TAK-071, a Muscarinic M1 Receptor Positive Allosteric Modulator with Low Cooperativity, For the Treatment of Cognitive Deficits and Negative Symptoms Associated with Schizophrenia.

  2021cites this paper
• Metabotropic glutamate receptors in GtoPdb v.2021.3

  2021cites this paper
• Neonatal maternal separation affects metabotropic glutamate receptor 5 expression and anxiety‐related behavior of adult rats

  2021cites this paper
• Loss of retinoid X receptor gamma subunit impairs group 1 mGluR mediated electrophysiological responses and group 1 mGluR dependent behaviors

  2021cites this paper
• Multi-sensory (auditory and somatosensory) pre-pulse inhibition in mice.

  2020cites this paper
• Microbiome Profiling Reveals Gut Dysbiosis in the Metabotropic Glutamate Receptor 5 Knockout Mouse Model of Schizophrenia

  2020cites this paper
• ZFP804A mutant mice display sex-dependent schizophrenia-like behaviors

  2020cites this paper
• Mesenchymal stem cells derived extracellular vesicles improve behavioral and biochemical deficits in a phencyclidine model of schizophrenia

  2020cites this paper
• In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis.

  2019cites this paper
• Cholinergic Neurons of the Medial Septum Are Crucial for Sensorimotor Gating

  2019cites this paper
• Metabotropic glutamate receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• A single early-life seizure results in long-term behavioral changes in the adult Fmr1 knockout mouse.

  2019influential citation
• GABAergic Abnormalities Associated with Sensorimotor Cortico-striatal Community Structural Deficits in ErbB4 Knockout Mice and First-Episode Treatment-Naïve Patients with Schizophrenia

  2019cites this paper
• Discovery and Development of Non-Dopaminergic Agents for the Treatment of Schizophrenia: Overview of the Preclinical and Early Clinical Studies.

  2019cites this paper
• Neuronal subset-specific Pten-deficient mice do not exhibit deficits in sensorimotor gating processes

  2019cites this paper
• Neuronal subset-specific-deficient mice do not exhibit Pten deficits in sensorimotor gating processes

  2019cites this paper
• mGlu5 in GABAergic neurons modulates spontaneous and psychostimulant-induced locomotor activity

  2019cites this paper
• Role of a PTP1B Pathway in the Neuropsychiatric Expression of a Mouse Maternal Immune Activation Model

  2019cites this paper
• Altered expression of schizophrenia-related genes in mice lacking mGlu5 receptors

  2018cites this paper
• A postmortem analysis of NMDA ionotropic and group 1 metabotropic glutamate receptors in the nucleus accumbens in schizophrenia.

  2018cites this paper
• The therapeutic potential of metabotropic glutamate receptor modulation for schizophrenia

  2018cites this paper
• Testing the efficacy of LSN 2463359 , a metabotropic glutamate 5 receptor positive allosteric modulator , in animal models of schizophrenia

  2018cites this paper
• A postmortem analysis of NMDA ionotropic and group 1 metabotropic glutamate receptors in the nucleus accumbens in schizophrenia.

  2018cites this paper
• Does genetic BDNF deficiency in rats interact with neurotransmitter control of prepulse inhibition? Implications for schizophrenia

  2017cites this paper
• Metabotropic glutamate receptor 5 neuroimaging in schizophrenia.

  2017cites this paper
• An examination of the roles of glutamate and sex in latent inhibition: Relevance to the glutamate hypothesis of schizophrenia?

  2017cites this paper
• 1 Metabotropic Receptors for Glutamate and GABA

  2017cites this paper
• Investigating the pharmacology, dimerisation and receptor-dependent toxicology of metabotropic glutamate receptor 5

  2017cites this paper
• Metabotropic glutamate receptors as emerging research targets in bipolar disorder.

  2017cites this paper
• Targeting metabotropic glutamate receptors for novel treatments of schizophrenia

  2017cites this paper
• Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders.

  2017cites this paper
• Changes in the expression of metabotropic glutamate receptor 5 (mGluR5) in a ketamine-based animal model of schizophrenia.

  2017cites this paper
• Animal Models: Citations

  2016cites this paper
• Metabotropic Glutamate Receptors in Central Nervous System Diseases.

  2016cites this paper
• Metabotropic glutamate receptors as targets for new antipsychotic drugs: Historical perspective and critical comparative assessment.

  2016cites this paper
• Neurodevelopmental Expression Profile of Dimeric and Monomeric Group 1 mGluRs: Relevance to Schizophrenia Pathogenesis and Treatment

  2016cites this paper
• Group I Metabotropic Glutamate Receptor Interacting Proteins: Fine-Tuning Receptor Functions in Health and Disease

  2016cites this paper
• Metabotropic glutamate receptor subtype 5: molecular pharmacology, allosteric modulation and stimulus bias

  2016cites this paper
• CALCIUM REGULATION OF CELL-CELL COMMUNICATION AND EXTRACELLULAR SIGNALING

  2016cites this paper
• The Glutamate mGluR5 Receptor as a Pharmacological Target to Enhance Cognitive Function: Emerging Evidence from Psychosis Models

  2016cites this paper
• Protein kinase A directly phosphorylates metabotropic glutamate receptor 5 to modulate its function

  2015cites this paper
• Environmental Enrichment Ameliorates Behavioral Impairments Modeling Schizophrenia in Mice Lacking Metabotropic Glutamate Receptor 5

  2015cites this paper
• Group I and group II metabotropic glutamate receptor allosteric modulators as novel potential antipsychotics.

  2015cites this paper
• Combined behavioral studies and in vivo imaging of inflammatory response and expression of mGlu5 receptors in schnurri-2 knockout mice.

  2015cites this paper
• Testing the efficacy of LSN2463359, a metabotropic glutamate 5 receptor positive allosteric modulator, in animal models of schizophrenia

  2015cites this paper
• Disruption of mGluR5 in parvalbumin-positive interneurons induces core features of neurodevelopmental disorders

  2015cites this paper
• Development of allosteric modulators of GPCRs for treatment of CNS disorders.

  2014cites this paper
• Screening of a Histone Methyltransferase Inhibitor in Animal Models of Psychiatric Illness

  2014cites this paper
• The Mauthner-cell circuit of fish as a model system for startle plasticity.

  2014cites this paper
• Anhedonia, avolition, and anticipatory deficits: assessments in animals with relevance to the negative symptoms of schizophrenia.

  2014cites this paper
• Metabotropic glutamate receptor 5 in the pathology and treatment of schizophrenia.

  2013cites this paper
• Phospholipase C-β1 and schizophrenia-related behaviors.

  2013cites this paper
• Prepulse inhibition predicts working memory performance whilst startle habituation predicts spatial reference memory retention in C57BL/6 mice.

  2013cites this paper
• Repeated potentiation of the metabotropic glutamate receptor 5 and the alpha 7 nicotinic acetylcholine receptor modulates behavioural and GABAergic deficits induced by early postnatal phencyclidine (PCP) treatment.

  2013cites this paper
• Metabotropic glutamate receptor 5 binding and protein expression in schizophrenia and following antipsychotic drug treatment.

  2013cites this paper
• Iron deficiency with or without anemia impairs prepulse inhibition of the startle reflex

  2013cites this paper
• mGluR5 Ablation in Cortical Glutamatergic Neurons Increases Novelty-Induced Locomotion

  2013cites this paper
• Modulation of basal ganglia function by metabotropic glutamate receptors

  2013influential citation
• Support for the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia from exome sequencing in multiplex families.

  2013cites this paper
• Molecular genetics of bipolar disorder

  2013cites this paper
• Chapter 30 – Modeling Schizophrenia in Animals

  2013cites this paper
• Enhancement of social novelty discrimination by positive allosteric modulators at metabotropic glutamate 5 receptors: adolescent administration prevents adult-onset deficits induced by neonatal treatment with phencyclidine

  2012cites this paper
• 1 ‘ Missing Heritability ’ ? Evaluating Genetic Evidence for Schizophrenia Risk Genes

  2012cites this paper
• Test‐retest stability of cerebral mGluR5 quantification using [11C]ABP688 and positron emission tomography in rats

  2012cites this paper
• Metabotropic glutamate receptors as targets for novel antipsychotic treatments.

  2012cites this paper
• Disturbed function of GABAergic interneurons in schizophrenia: relevance for medical treatment?

  2012cites this paper
• Susceptibility genes for schizophrenia: mutant models, endophenotypes and psychobiology.

  2012cites this paper
• Metabotropic glutamate receptors for new treatments in schizophrenia.

  2012cites this paper
• Assoziation von Single Nucleotid Polymorphismen im GRM5-Gen mit Schizophrenie und kognitiven Phänotypen

  2012cites this paper
• Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders.

  2012cites this paper
• Behavioral animal models of antipsychotic drug actions.

  2012cites this paper
• Emerging approaches for treatment of schizophrenia: modulation of glutamatergic signaling.

  2012cites this paper
• Metabotropic Receptors for Glutamate and GABA

  2012cites this paper
• Machine learning algorithms for prediction of biological activity and chemical properties

  2011cites this paper
• Altered levels of glutamatergic receptors and Na+/K+ ATPase-α1 in the prefrontal cortex of subjects with schizophrenia.

  2011influential citation
• Pallidal Hyperdopaminergic Innervation Underlying D2 Receptor-Dependent Behavioral Deficits in the Schizophrenia Animal Model Established by EGF

  2011cites this paper
• Patients with premenstrual dysphoric disorder have increased startle modulation during anticipation in the late luteal phase period in comparison to control subjects.

  2011cites this paper
• AFQ056, a new mGluR5 antagonist for treatment of fragile X syndrome.

  2011cites this paper
• Metabotropic glutamate receptors: from the workbench to the bedside.

  2011cites this paper
• Targeting glutamate synapses in schizophrenia.

  2011cites this paper
• A new method for modulating the activity of parvalbumin- positive neurons and cerebellar Purkinje cells in vivo

  2011cites this paper
• Removal of GABAA Receptor γ2 Subunits from Parvalbumin Neurons Causes Wide-Ranging Behavioral Alterations

  2011cites this paper
• Allosteric modulation of metabotropic glutamate receptors.

  2011cites this paper
• Modeling the Positive Symptoms of Schizophrenia in Genetically Modified Mice: Pharmacology and Methodology Aspects

  2010cites this paper
• The glutamatergic compounds sarcosine and N-acetylcysteine ameliorate prepulse inhibition deficits in metabotropic glutamate 5 receptor knockout mice

  2010cites this paper